Could protein content of Urinary Extracellular Vesicles be useful to detect Cirrhosis in Alcoholic Liver Disease?


Journal

International journal of biological sciences
ISSN: 1449-2288
Titre abrégé: Int J Biol Sci
Pays: Australia
ID NLM: 101235568

Informations de publication

Date de publication:
2021
Historique:
received: 23 02 2021
accepted: 10 04 2021
entrez: 16 6 2021
pubmed: 17 6 2021
medline: 26 3 2022
Statut: epublish

Résumé

Alcohol abuse has a high impact on the mortality and morbidity related to a great number of diseases and is responsible for the development of alcoholic liver disease (ALD). It remains challenging to detect and evaluate its severity, which is crucial for prognosis. In this work, we studied if urinary EVs (uEVs) could serve in diagnose and evaluate cirrhosis in ALD. To this purpose, uEVs characterization by cryo-electron microscopy (Cryo-EM), Nanoparticle Tracking Analysis (NTA) and Western blotting (WB) was performed in a cohort of 21 controls and 21 cirrhotic patients. Then, proteomics of uEVs was carried out in a second cohort of 6 controls and 8 patients in order to identify new putative biomarkers for cirrhosis in ALD. Interestingly, uEVs concentration, size and protein composition were altered in cirrhotic patients. From a total of 1304 proteins identified in uEVs, 90 of them were found to be altered in cirrhotic patients. The results suggest that uEVs could be considered as a tool and a supplier of new biomarkers for cirrhosis in ALD, whose application would be especially relevant in chronic patients. Yet, further research is necessary to obtain more relevant result in clinical terms.

Identifiants

pubmed: 34131392
doi: 10.7150/ijbs.59725
pii: ijbsv17p1864
pmc: PMC8193259
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1864-1877

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

Yonsei Med J. 2020 Oct;61(10):891-894
pubmed: 32975064
Mol Ther. 2020 Feb 5;28(2):479-489
pubmed: 31757759
Sci Rep. 2017 Dec 8;7(1):17238
pubmed: 29222479
J Cell Mol Med. 2019 Jan;23(1):70-82
pubmed: 30450735
Alcohol Res. 2013;35(2):155-73
pubmed: 24881324
Gastroenterology. 2011 Nov;141(5):1572-85
pubmed: 21920463
J Transl Med. 2015 Aug 12;13:261
pubmed: 26264599
Cancer Cell Int. 2016 Feb 29;16:15
pubmed: 26933386
Hepatol Commun. 2020 Jul 03;4(9):1263-1278
pubmed: 32923831
Infect Genet Evol. 2020 Nov;85:104422
pubmed: 32544615
Alcohol Clin Exp Res. 1989 Jun;13(3):444-8
pubmed: 2665561
Cell Death Dis. 2019 Oct 7;10(10):758
pubmed: 31591383
J Lab Clin Med. 1989 Apr;113(4):493-7
pubmed: 2703760
Cancers (Basel). 2020 Jan 09;12(1):
pubmed: 31936571
Jpn J Clin Oncol. 2018 Jan 01;48(1):52-60
pubmed: 29145632
Hepatol Commun. 2017 Jul 13;1(7):675-690
pubmed: 29404485
Cancer. 2018 Jul 1;124(13):2748-2757
pubmed: 29669170
Addiction. 2017 Jun;112(6):968-1001
pubmed: 28220587
Hepatol Int. 2016 Jan;10(1):124-32
pubmed: 26420218
J Clin Transl Hepatol. 2015 Jun 28;3(2):109-16
pubmed: 26356792
Cell. 2020 Aug 6;182(3):563-577.e20
pubmed: 32615086
Int J Mol Sci. 2020 Jul 11;21(14):
pubmed: 32664576
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Am J Gastroenterol. 2020 Nov;115(11):1775-1785
pubmed: 33156095
J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S7-S20
pubmed: 26041962
FASEB J. 2002 Jul;16(9):935-42
pubmed: 12087054
PLoS One. 2015 Aug 07;10(8):e0134302
pubmed: 26252713
Eur J Intern Med. 2017 Sep;43:e48-e49
pubmed: 28502865
Hepatology. 2018 Oct;68(4):1508-1518
pubmed: 29603327
Cell Death Dis. 2019 Jan 25;10(2):71
pubmed: 30683843
PLoS One. 2012;7(2):e30796
pubmed: 22355327
Lancet. 2009 Jun 27;373(9682):2223-33
pubmed: 19560604
Neurotherapeutics. 2020 Jan;17(1):127-141
pubmed: 31713188
Alcohol Clin Exp Res. 2019 Jul;43(7):1439-1451
pubmed: 31009094
Histopathology. 2004 Oct;45(4):335-42
pubmed: 15469471
Kidney Int. 2015 Mar;87(3):610-22
pubmed: 25207879
Int J Radiat Biol. 2018 Apr;94(4):315-326
pubmed: 29424599
J Hepatol. 2016 Nov;65(5):963-971
pubmed: 27318326
Cells. 2020 Feb 25;9(3):
pubmed: 32106390
World J Gastroenterol. 2017 Dec 28;23(48):8439-8442
pubmed: 29358853
Expert Rev Mol Diagn. 2015;15(7):907-23
pubmed: 25948243
Clin Chim Acta. 2018 Oct;485:158-165
pubmed: 29966621
Int J Biol Sci. 2015 Jun 11;11(8):961-9
pubmed: 26157350
Ann Hepatol. 2018 Jun 4;17(4):547-560
pubmed: 29893696
World J Hepatol. 2012 Mar 27;4(3):81-90
pubmed: 22489260
Biochimie. 2020 Oct;177:132-141
pubmed: 32835735
Hepatology. 2011 May;53(5):1549-57
pubmed: 21520170
J Hepatol. 2018 Jul;69(1):154-181
pubmed: 29628280
Mol Cell Biochem. 2016 Jul;418(1-2):81-90
pubmed: 27334756
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1090-5
pubmed: 24395807
Nat Commun. 2020 Sep 7;11(1):4489
pubmed: 32895384
Liver Int. 2020 Jan;40(1):18-31
pubmed: 31580514
Cell Death Dis. 2020 Jul 9;11(7):518
pubmed: 32647111
J Hepatol. 2021 Feb;74(2):469-471
pubmed: 33096086
Cells. 2020 Mar 27;9(4):
pubmed: 32231001
Clin Biochem. 2001 May;34(3):189-93
pubmed: 11408016
Hepatology. 2012 Nov;56(5):1946-57
pubmed: 22684891
Cancer. 2005 Feb 1;103(3):588-98
pubmed: 15612021
J Hepatol. 2015 Apr;62(1 Suppl):S38-46
pubmed: 25920088
J Cell Mol Med. 2018 Mar;22(3):1873-1882
pubmed: 29363860
Liver Int. 2019 Feb;39(2):299-306
pubmed: 30261128
Lancet. 2014 May 17;383(9930):1749-61
pubmed: 24480518
Free Radic Biol Med. 2019 Nov 1;143:127-139
pubmed: 31351176
Hepatology. 2021 Jan;73(1):471-472
pubmed: 33227154
Gut Liver. 2017 Mar 15;11(2):276-282
pubmed: 27728964
J Hepatol. 2001 Aug;35(2):290-4
pubmed: 11580154
Arch Intern Med. 1982 May;142(5):893-5
pubmed: 6282229
Endocr Regul. 2015 Jan;49(1):20-4
pubmed: 25687677
Thromb Res. 2007;120(2):289-93
pubmed: 17049585
Health Sci Rep. 2020 Feb 13;3(1):e146
pubmed: 32166191
Adv Exp Med Biol. 2015;815:217-38
pubmed: 25427910
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
J Clin Med. 2019 Mar 27;8(4):
pubmed: 30934723
J Neuroinflammation. 2018 Aug 22;15(1):234
pubmed: 30134917
Cancers (Basel). 2019 Oct 23;11(11):
pubmed: 31652837
PLoS One. 2017 Feb 22;12(2):e0172463
pubmed: 28225807
Pharmacol Ther. 2021 Feb;218:107683
pubmed: 32961265
Oxid Med Cell Longev. 2020 Jan 18;2020:4213541
pubmed: 32051731
Mol Biotechnol. 2009 Nov;43(3):221-31
pubmed: 19672731
J Exp Clin Cancer Res. 2019 Apr 11;38(1):154
pubmed: 30971297
J Hepatol. 1997 Aug;27(2):358-62
pubmed: 9288611
J Proteomics. 2014 May 30;103:227-40
pubmed: 24747303
J Lipid Res. 2020 Jul;61(7):1075-1086
pubmed: 32430316
J Physiol Pharmacol. 2020 Apr;71(2):
pubmed: 32633236
Hepatology. 2017 Feb;65(2):475-490
pubmed: 27639178
World J Gastroenterol. 2014 Sep 7;20(33):11684-99
pubmed: 25206273
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
World J Gastroenterol. 2017 May 21;23(19):3396-3406
pubmed: 28596676
Biochem Biophys Res Commun. 2015 Mar 27;459(1):18-23
pubmed: 25701390
World J Gastroenterol. 2015 Nov 14;21(42):11914-23
pubmed: 26576080
JHEP Rep. 2020 Oct;2(5):100169
pubmed: 32835190
Acta Physiol (Oxf). 2020 Jan;228(1):e13346
pubmed: 31334916
Int J Mol Sci. 2020 Apr 04;21(7):
pubmed: 32260425
Trends Mol Med. 2018 May;24(5):458-471
pubmed: 29665983
J Pharmacol Exp Ther. 2020 Sep;374(3):512-520
pubmed: 32571958
Oncotarget. 2015 Apr 30;6(12):10045-59
pubmed: 25826090
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):455-466
pubmed: 28634412
Proteomics Clin Appl. 2010 Apr;4(4):416-25
pubmed: 20535238
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Nat Rev Dis Primers. 2018 Aug 16;4(1):16
pubmed: 30115921
Front Physiol. 2019 Nov 19;10:1421
pubmed: 31803070
J Hepatol. 2017 Nov;67(5):1018-1025
pubmed: 28647568
Indian J Pathol Microbiol. 2018 Oct-Dec;61(4):510-515
pubmed: 30303139
Pharmacol Ther. 2018 Jul;187:180-194
pubmed: 29621595
Autophagy. 2013 Jun 1;9(6):925-7
pubmed: 23518600
PLoS One. 2013 Jun 26;8(6):e64709
pubmed: 23840303
Clin Sci (Lond). 2020 Jun 26;134(12):1301-1304
pubmed: 32542396
J Neuroimmune Pharmacol. 2020 Sep;15(3):409-421
pubmed: 30955131
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970
Int J Mol Sci. 2020 Jul 03;21(13):
pubmed: 32635162
Oncology. 1997 Jan-Feb;54(1):79-83
pubmed: 8978598
Drug Alcohol Depend. 2014 Oct 1;143:112-9
pubmed: 25107314
Cell Mol Life Sci. 2010 Jan;67(1):89-98
pubmed: 19763395
Int J Mol Med. 2001 Jan;7(1):67-71
pubmed: 11115611
Clin Biochem. 2016 Sep;49(13-14):1078-91
pubmed: 27208822
Gastroenterology. 2008 Jul;135(1):244-256.e1
pubmed: 18466772
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394
Clin Transl Oncol. 2014 Jan;16(1):57-63
pubmed: 23632812

Auteurs

Esperanza Gonzalez (E)

Exosomes Laboratory. Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.

Mikel Azkargorta (M)

Proteomics Platform. Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.

Clara Garcia-Vallicrosa (C)

Exosomes Laboratory. Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.

Janire Prieto-Elordui (J)

Servicio de Aparato Digestivo, Hospital Universitario de Basurto, Bilbao, Spain.

Felix Elortza (F)

Proteomics Platform. Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.

Sonia Blanco-Sampascual (S)

Servicio de Aparato Digestivo, Hospital Universitario de Basurto, Bilbao, Spain.

Juan Manuel Falcon-Perez (JM)

Exosomes Laboratory. Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas (CIBERehd), Madrid, Spain.
IKERBASQUE Basque Foundation for Science Bilbao Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH